November 19, 2026

Online Shop Review

Online Shop and Product Review

Pain Therapeutics stock plunges after company slams FDA for refusing to approve drug

1 min read

Pain Therapeutics stock plunges after company slams FDA for refusing to approve drug

Shares of Pain Therapeutics Inc. fell 18% Tuesday after the company released a statement railing against the U.S. Food and Drug Administration’s refusal to approve drug candidate Remoxy.

Read More…

Leave a Reply

Your email address will not be published. Required fields are marked *